Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
33.9M
-
Number of holders
-
68
-
Total 13F shares, excl. options
-
20.2M
-
Shares change
-
+5.09M
-
Total reported value, excl. options
-
$361M
-
Value change
-
+$93M
-
Number of buys
-
52
-
Number of sells
-
-15
-
Price
-
$17.92
Significant Holders of TransMedics Group, Inc. - Common Stock (TMDX) as of Q2 2020
73 filings reported holding TMDX - TransMedics Group, Inc. - Common Stock as of Q2 2020.
TransMedics Group, Inc. - Common Stock (TMDX) has 68 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20.2M shares
of 33.9M outstanding shares and own 59.4% of the company stock.
Largest 10 shareholders include FMR LLC (3.95M shares), ABRAMS CAPITAL MANAGEMENT, L.P. (3.5M shares), FEDERATED HERMES, INC. (1.53M shares), BlackRock Inc. (1.31M shares), CREDIT SUISSE AG/ (1.3M shares), VANGUARD GROUP INC (866K shares), Zimmer Partners, LP (844K shares), Sandhill Capital Partners LLC (756K shares), EMERALD ADVISERS, LLC (669K shares), and EMERALD MUTUAL FUND ADVISERS TRUST (608K shares).
This table shows the top 68 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.